Evidence map›Paper›PMID 35760568›Full record

ArticleJournal of medical radiation sciences2022

Philippa L Bresser, Janet Reed, Mike M Sathekge, Mariza Vorster

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical radiation sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Philippa L BresserDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0000-0002-9093-2957
Janet ReedDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Mike M SathekgeDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Mariza VorsterDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
University of Pretoria · ZAUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) lesions in humans have been proven to be severely hypoxic with hypoxia leading to latency and dormancy of disease. Dormant TB lesions become less susceptible to standard TB treatment regimens with varying responses to treatment but may have increased susceptibility to nitroimidazole drugs. This in turn implies that positron emission tomography / computed tomography (PET/CT) imaging with radiolabelled nitroimidazoles may identify patients who will benefit from treatment with antimicrobial agents that are active against anaerobic bacteria. This case series aims to highlight the hypoxic uptake and retention of a novel

Indexed as

NitroimidazolesTuberculosisGallium RadioisotopesHumansHypoxiaPositron-Emission TomographyPositron Emission Tomography Computed TomographyGallium-68Gallium RadioisotopesNitroimidazoles68Ga-nitroimidazoleHypoxiaindividualised therapyPET/CTtuberculosis

Identifiers

PMID35760568
PMCPMC9714510
OpenAlexW4283661329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.